Siddhivinayak Diagnostics Centre Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-12-2024
- Paid Up Capital ₹ 0.16 M
as on 16-12-2024
- Company Age 15 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 10.39%
(FY 2019)
- Profit 6431.82%
(FY 2019)
- Ebitda 8.63%
(FY 2019)
- Net Worth 96.86%
(FY 2019)
- Total Assets 4.94%
(FY 2019)
About Siddhivinayak Diagnostics Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.16 M, as per Ministry of Corporate Affairs (MCA) records.
Rajendra Gorhe, Vishnu Atre, Abhijit Kakade, and Eleven other members serve as directors at the Company.
- CIN/LLPIN
U85100MH2009PTC195013
- Company No.
195013
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Aug 2009
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Siddhivinayak Diagnostics Centre?
Board Members(14)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Gorhe  | Director | 12-Mar-2015 | Current |
| Vishnu Atre | Director | 18-Aug-2009 | Current |
| Abhijit Kakade | Director | 01-Jan-2012 | Current |
| Bharat Gare | Director | 18-Aug-2009 | Current |
| Arun Thorat | Director | 01-Jan-2012 | Current |
| Pankaj Navandar | Director | 18-Aug-2009 | Current |
Financial Performance of Siddhivinayak Diagnostics Centre.
Siddhivinayak Diagnostics Centre Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 10.39% increase. The company also saw a substantial improvement in profitability, with a 6431.82% increase in profit. The company's net worth Soared by an impressive increase of 96.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Siddhivinayak Diagnostics Centre?
In 2017, Siddhivinayak Diagnostics Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Siddhivinayak Diagnostics Centre?
Siddhivinayak Diagnostics Centre has a workforce of 6 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Siddhivinayak Diagnostics Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siddhivinayak Diagnostics Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
